The Centers for Disease Control and Prevention has released evidence-based recommendations to prevent and control Staphylococcus aureus in neonatal intensive care units, including strains resistant (MRSA) or sensitive (MSSA) to the antibiotic methicillin.

The recommendations supplement existing CDC recommendations for all health care settings based on a systematic review of the best available literature, the agency said.

“While MRSA has long been the focus of prevention efforts due to the difficulty in treating and eradicating it, recent studies have demonstrated that methicillin-sensitive S. aureus (MSSA) has morbidity and mortality equal to MRSA and occurs more frequently in NICU patients,” the guidelines note.

Related News Articles

Headline
The AHA Quest for Quality Prize honors hospitals and health systems committed to leadership and innovation in improving quality and advancing health. Learn how…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Blog
Read about the 2025 Quest for Quality Prize winner and finalist — and apply for the 2026 awardEach day, health care professionals across the U.S. leverage…
Perspective
Public
Hospitals and health systems across the country vary in size, as well as the types of services and specialties they offer. They also offer many different…
Headline
The AHA Aug. 7 launched a new webpage, Reducing Disparities in Health Outcomes, featuring new and familiar resources for members and their communities. As part…
Headline
Nell Buhlman, chief administrative officer and head of strategy at Press Ganey, and Chris DeRienzo, M.D., AHA chief physician executive, explore the data-…